SOW
SNDX icon

State of Wyoming’s Syndax Pharmaceuticals SNDX Stock Holding History

State of Wyoming’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,242
Closed -$68.5K – 1761
2023
Q1 		$68.5K Buy
+3,242
New +$80.6K 0.02% 969
2022
Q4 		– Sell
-1,234
Closed -$30K – 1750
2022
Q3 		$30K Buy
1,234
+102
+9% +$2.29K 0.01% 1185
2022
Q2 		$22K Sell
1,132
-4,801
-81% -$80K 0.01% 1392
2022
Q1 		$103K Buy
5,933
+4,181
+239% +$70.4K 0.05% 569
2021
Q4 		$38K Buy
1,752
+172
+11% +$3.18K 0.02% 1232
2021
Q3 		$30K Buy
1,580
+871
+123% +$14.5K 0.02% 880
2021
Q2 		$12K Buy
+709
New +$13K 0.01% 996

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State of Wyoming's SNDX Position: Q2 2023 in Review

State of Wyoming sold out of Syndax Pharmaceuticals (SNDX) in Q2 2023, closing a stake of 3,242 shares — an estimated $68.5K sold.

State of Wyoming first reported a position in SNDX in Q2 2021 and held it in 7 quarters. The position peaked at $103K in Q1 2022. 166 funds tracked by Wall St. Rank hold SNDX as of Q2 2023.

  • State of Wyoming reported no remaining Syndax Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 3,242 Syndax Pharmaceuticals shares in Q2 2023, an estimated $68.5K.
  • State of Wyoming first reported a position in Syndax Pharmaceuticals in Q2 2021 and held it in 7 quarters.
  • State of Wyoming's Syndax Pharmaceuticals position peaked at $103K in Q1 2022.
  • 166 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.